News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
180,505 Results
Type
Article (31981)
Company Profile (12)
Press Release (148512)
Section
Business (54799)
Career Advice (375)
Deals (3886)
Drug Delivery (9)
Drug Development (24718)
Employer Resources (34)
FDA (3390)
Job Trends (3324)
News (85087)
Policy (4862)
Tag
2024 Biotech Bay Standard (2)
2024 Pharm Country Standard (1)
2026 Biotech Bay Standard (1)
Academia (2404)
Academic (1)
Accelerated approval (2)
Adcomms (7)
Allergies (18)
Alliances (11605)
ALS (25)
Alzheimer's disease (518)
Antibody-drug conjugate (ADC) (19)
Approvals (3413)
Artificial intelligence (56)
Autoimmune disease (1)
Automation (4)
Bankruptcy (27)
Best Places to Work (2779)
BIOSECURE Act (3)
Biosimilars (8)
Biotechnology (19)
Bladder cancer (18)
Brain cancer (8)
Breast cancer (92)
Cancer (579)
Cardiovascular disease (39)
Career advice (345)
Career pathing (8)
CAR-T (41)
Cell therapy (110)
Cervical cancer (6)
Clinical research (19161)
Collaboration (158)
Compensation (8)
Complete response letters (1)
COVID-19 (1208)
CRISPR (11)
C-suite (131)
Cystic fibrosis (23)
Data (676)
Decentralized trials (1)
Denatured (3)
Depression (6)
Diabetes (51)
Diagnostics (1699)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (22)
Drug pricing (9)
Drug shortages (1)
Duchenne muscular dystrophy (19)
Earnings (7534)
Editorial (3)
Employer branding (3)
Employer resources (30)
Events (19023)
Executive appointments (416)
FDA (3615)
Featured Employer (3)
Frontotemporal dementia (4)
Funding (205)
Gene editing (31)
Generative AI (2)
Gene therapy (72)
GLP-1 (126)
Government (1059)
Guidances (3)
Healthcare (5418)
Huntington's disease (2)
IgA nephropathy (6)
Immunology and inflammation (10)
Indications (8)
Infectious disease (1239)
Inflammatory bowel disease (40)
Inflation Reduction Act (1)
Influenza (15)
Intellectual property (14)
Interviews (43)
IPO (1735)
IRA (7)
Job creations (615)
Job search strategy (324)
Kidney cancer (4)
Labor market (5)
Layoffs (34)
Leadership (2)
Legal (975)
Liver cancer (19)
Lung cancer (79)
Lymphoma (40)
Machine learning (1)
Management (9)
Manufacturing (37)
MASH (23)
Medical device (3173)
Medtech (3174)
Mergers & acquisitions (2200)
Metabolic disorders (113)
Multiple sclerosis (17)
NASH (5)
Neurodegenerative disease (23)
Neuropsychiatric disorders (1)
Neuroscience (631)
NextGen: Class of 2025 (1920)
Non-profit (1822)
Northern California (587)
Now hiring (3)
Obesity (39)
Opinion (27)
Ovarian cancer (30)
Pain (14)
Pancreatic cancer (24)
Parkinson's disease (31)
Partnered (5)
Patents (40)
Patient recruitment (30)
Peanut (12)
People (32783)
Phase I (6064)
Phase II (8820)
Phase III (5820)
Pipeline (177)
Podcasts (4)
Policy (20)
Postmarket research (979)
Preclinical (3151)
Press Release (25)
Prostate cancer (27)
Psychedelics (8)
Radiopharmaceuticals (73)
Rare diseases (84)
Real estate (1375)
Recruiting (16)
Regulatory (3252)
Reports (3)
Research institute (1378)
Resumes & cover letters (23)
Rett syndrome (2)
RNA editing (1)
RSV (1)
Schizophrenia (8)
Series A (26)
Series B (19)
Service/supplier (1)
Sickle cell disease (16)
Southern California (462)
Spinal muscular atrophy (38)
Sponsored (6)
Startups (1128)
Stomach cancer (1)
Tariffs (1)
The Weekly (1)
United States (4621)
Vaccines (202)
Venture capitalists (1)
Webinars (9)
Weight loss (22)
Women's health (6)
Worklife (2)
Date
Today (25)
Last 7 days (166)
Last 30 days (623)
Last 365 days (7618)
2025 (1784)
2024 (7938)
2023 (9750)
2022 (12140)
2021 (13961)
2020 (13515)
2019 (13165)
2018 (9776)
2017 (9045)
2016 (9228)
2015 (10648)
2014 (8091)
2013 (7832)
2012 (7782)
2011 (7854)
2010 (7239)
Location
Africa (265)
Alabama (11)
Alaska (3)
Arizona (41)
Arkansas (6)
Asia (10441)
Australia (2613)
California (1232)
Canada (727)
China (93)
Colorado (56)
Connecticut (61)
Delaware (28)
Europe (27669)
Florida (154)
Georgia (48)
Idaho (12)
Illinois (119)
India (3)
Indiana (58)
Iowa (2)
Japan (41)
Kansas (13)
Kentucky (4)
Louisiana (3)
Maine (12)
Maryland (153)
Massachusetts (793)
Michigan (37)
Minnesota (62)
Mississippi (1)
Missouri (19)
Montana (6)
Nebraska (4)
Nevada (10)
New Hampshire (8)
New Jersey (354)
New Mexico (8)
New York (365)
North Carolina (259)
North Dakota (3)
Northern California (587)
Ohio (64)
Oklahoma (5)
Oregon (9)
Pennsylvania (276)
Puerto Rico (1)
Rhode Island (8)
South America (293)
South Carolina (5)
Southern California (462)
Tennessee (25)
Texas (189)
Utah (38)
Virginia (31)
Washington D.C. (18)
Washington State (147)
West Virginia (1)
Wisconsin (8)
180,505 Results for "columbia university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski
March 19, 2025
·
4 min read
Press Releases
Alaya.bio Expands in situ CAR-T Therapy Collaboration with Michel Sadelain and Columbia University
January 21, 2025
·
2 min read
Press Releases
Baird Medical Advances MWA Training with Expert-Led Course at Columbia Thyroid Center
February 10, 2025
·
4 min read
Press Releases
Medexus and British Columbia’s Provincial Health Services Authority (PHSA) Successfully Complete Agreement for Public Reimbursement of Trecondyv (treosulfan for injection) in British Columbia, Canada
January 15, 2025
·
8 min read
Press Releases
George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Columbia and Central America
January 14, 2025
·
6 min read
Policy
PreveCeutical Commences Litigation Against Former Legal Counsel in the British Columbia Supreme Court Alleging Professional Negligence
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the “Company” or “PreveCeutical”), announces that it, along with certain others, filed a Notice of Civil Claim (the “Claim”) in the British Columbia Supreme Court on June 5, 2024 against its former legal counsel (the “Defendants”).
June 6, 2024
·
5 min read
Press Releases
Sable Therapeutics Announces Exclusive Worldwide Licensing Agreement with Columbia University to Develop Novel Polycation Nanomedicines for the Treatment of Obesity
August 12, 2024
·
2 min read
Business
NRx Pharmaceuticals Announces Signing of a Data and Technical Information Agreement with Columbia University Accessing Key Data Demonstrating Efficacy and Safety of Intravenous Ketamine for the Treatment of Suicidal Depression
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical-stage biopharmaceutical company, today announced that it has signed a License Data and Technical Information Agreement with Columbia University for rights to data from a randomized, active-controlled trial of 80 patients hospitalized for Acute Suicidality in Depression.
December 19, 2023
·
4 min read
Business
Thylacine Biotherapeutics Licenses Novel Antiviral Peptide Platform from Columbia University
Thylacine Biotherapeutics Inc. (“Thylacine Bio”), a privately held biotech company dedicated to combating infectious disease, announced today it has entered into a license agreement with Columbia University (“Columbia”) for worldwide exclusive rights to develop and commercialize a novel antiviral peptide platform.
February 14, 2023
·
2 min read
Drug Development
ElmediX Plans Series A Round Based on Strong Signals in a Clinical Study for Pancreatic Cancer Patients at the University Hospital Antwerp (Belgium)
Earlier this year, scientists from Columbia University in New York demonstrated that the growth rate of pancreatic cancer, measured in patients’ blood using CA19-9 as biomarker, determines survival chances and can be used as a quick way to assess treatment effectiveness.
June 14, 2024
·
3 min read
1 of 18,051
Next
